Diagnóstica Longwood
Diagnóstica Longwood is a privately held Spanish distributor founded in 1992, headquartered in Zaragoza, that resells in vitro diagnostic products from 40+ international manufacturers to diagnostic and research laboratories in Spain, Portugal, and Uruguay, providing technical consultation and workflow support.
- Company typePrivate
- Founded1992
- HeadquartersZaragoza, Spain
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Diagnóstica Longwood does
Diagnóstica Longwood is a privately held Spanish distributor (DIAGNOSTICA LONGWOOD S.L.U.) founded in 1992 and headquartered in Zaragoza, specializing in in vitro diagnostic (IVD) products for molecular biology. The company does not develop proprietary technology; instead it curates, distributes, and provides technical support for a portfolio of more than 40 international manufacturers spanning next-generation sequencing (Illumina, SOPHiA Genetics, Agilent, Twist Bioscience), qPCR and fragment analysis, spatial biology (Standard Biotools), HLA typing (GenDx, Inno-train), reproductive genetics (Yikon Genomics), transplantation diagnostics (CareDx), microbiology (Bruker, Certest, Arrow Diagnostics, Qiagen), and bioinformatics/clinical interpretation software (SOPHiA DDM GEN2, VarSome Clinical, SeqOne). Its customer base consists of diagnostic laboratories and research institutions in Spain, with secondary extension into Portugal and Uruguay; use cases include molecular diagnostics, oncology, hereditary cancer, reproductive genetics, microbiology, and immunology.
The business model is one-time resale of reagents, kits, instruments, and software licenses, augmented by deep technical services — expert scientific advisors provide assay setup, protocol development, workflow optimization, and ongoing consultation. The company operates owned inventory in Spain with dedicated warehouse and laboratory facilities in Zaragoza, plus sales offices in Madrid and Barcelona. Go-to-market is sales-led, combining direct field engagement with participation in major scientific congresses (SEHH-SETH, SEIMC, SEI, ECCMID), sponsored events, and educational webinars. Pricing is not publicly disclosed and is negotiated on a case-by-case basis typical of B2B specialized laboratory supply. The company holds ISO 9001 quality management certification and ENS (Spanish National Security Framework) cybersecurity certification under Royal Decree 311/2022.
Strategically, the company has evolved from a pure Spain-focused distributor into a multi-country Iberian/LATAM platform with regional headquarters in Montevideo (Uruguay) and Lisbon (Portugal). The two flagship analytical platforms — SOPHiA DDM GEN2 (AI-powered clinical genomics) and VarSome Clinical (CE-IVDR NGS interpretation) — anchor a positioning that emphasizes complete end-to-end workflows from sample preparation through clinical interpretation, while the underlying AI/ML capability resides with the OEMs rather than with Diagnóstica Longwood itself.
Diagnóstica Longwood firmographics
Firmographics- Name
- Diagnóstica Longwood
- Legal name
- DIAGNOSTICA LONGWOOD S.L.U.
- Website
- https://www.dlongwood.com
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Diagnóstica Longwood is a privately held Spanish distributor founded in 1992, headquartered in Zaragoza, that resells in vitro diagnostic products from 40+ international manufacturers to diagnostic and research laboratories in Spain, Portugal, and Uruguay, providing technical consultation and workflow support.
- Ownership category
- akta.pro rank
Diagnóstica Longwood industry classification
Industry- Product category
- In Vitro Diagnostics Distribution
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)
- akta.pro secondary industry
- Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC)
Keywords
Where Diagnóstica Longwood is headquartered
LocationHeadquarters
- HQ city
- Zaragoza
- HQ country
- Spain
- HQ region
- Europe
Offices7 records
Markets served
Diagnóstica Longwood business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales
Revenue model
- Distribution of In Vitro Diagnostic Products: Diagnóstica Longwood generates revenue through the distribution and resale of molecular biology diagnostic products, reagents, and equipment from international manufacturers to diagnostic and research laboratories in Spain and surrounding regions. The company maintains its own inventory in Spain and provides logistics, technical support, and consulting services alongside product sales.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Diagnóstica Longwood product offering
Product offeringCore offering
Diagnóstica Longwood is a specialized distributor of in vitro diagnostic products and solutions for molecular biology. The company curates and distributes products from over 40 international manufacturers spanning NGS, qPCR, fragment analysis, spatial biology, and bioinformatics software. It provides expert scientific consultation, assay setup, protocol development, workflow optimization, and logistics services to clinical diagnostic and research laboratories in Spain and selected international markets.
Product overview
Diagnóstica Longwood is a distributor of in vitro diagnostic products for molecular biology, representing a multi-brand portfolio of technologies rather than a single unified product. The portfolio is organized around two core analytical platforms — SOPHiA DDM GEN2 for AI-powered clinical genomics and VarSome Clinical for CE-IVDR NGS data interpretation — supplemented by specialized products across several domains. In reproductive genetics, the company offers preimplantation genetic testing solutions including KaryoSeq (integrated PGT-M/PGT-SR/PGT-A), MaReCs (carrier status determination), and PGT-SR (structural rearrangement analysis) from Yikon Genomics. Hereditary cancer testing includes HBOC, BRCA, and LynchFAP panels from Devyser and SOPHiA GENETICS. The portfolio also spans solid tumor profiling (HederaDx panels), microbiology (Arrow Diagnostics, Certest), whole genome/exome sequencing (Illumina, Twist), and HLA typing (inno-train). The company's offering emphasizes complete end-to-end workflows spanning from sample preparation through data analysis, with particular strength in NGS-based solutions.
Differentiator
Problem solved
Functional benefit
Products and services
- SOPHiA DDM GEN2 Analytical platform for clinical genomics that uses artificial intelligence to perform quality control, alignment, variant detection, annotation, and pre-classification into pathogenicity categories. Designed for clinical diagnostic laboratories conducting oncology, rare disease, and hereditary disorder testing.
- VarSome Clinical CE-IVDR certified platform for clinical interpretation of NGS data. Performs calling, annotation, classification and prioritisation of germline and somatic variants, integrating curated evidence from databases such as ClinVar, gnomAD, DECIPHER, OncoKB, CKB, and COSMIC to support diagnostic decisions.
- KaryoSeq Next-generation sequencing-based solution for preimplantation genetic testing that enables PGT-M, PGT-SR, and PGT-A within a single workflow. Based on MARSALA principle with whole-genome amplification of single cells using NGS technology. For IVF and reproductive genetics laboratories.
- MaReCs (Mapping allele with resolved carrier state test) PGT-SR technology that identifies aneuploid or euploid embryos and analyses translocation breakpoints and SNP linkage to differentiate carrier from non-carrier euploid embryos. Combines ChromSwift technology with NGS sequencing for reproductive genetics laboratories.
- Hedera Profiling 1 FFPE Test Panel (HP1) In-house targeted enrichment NGS panel for pan-cancer solid tumor profiling. Analyses 115 genes (79 with complete CDS) with ESCAT I, II and III clinical evidence, detecting SNVs, Indels, CNVs, fusions, structural variants, and MSI. For FFPE tissue samples.
- Devyser BRCA NGS Fast and robust NGS solution designed for detection of genetic variants in the BRCA1 and BRCA2 genes with comprehensive and uniform coverage of all coding exons and exon/intron junctions. For hereditary cancer testing laboratories.
- Devyser LynchFAP Targeted NGS solution for analysis of germline variants associated with hereditary colorectal cancer syndromes including Lynch syndrome, familial adenomatous polyposis (FAP), and MUTYH-associated polyposis (MAP).
- HLA-SuBiTo NGStype High-resolution NGS-based HLA typing system supporting multiple sequencing platforms using a long-range PCR approach for simultaneous analysis of up to 11 HLA loci. For HLA typing and transplantation diagnostics laboratories.
- OncoDEEP In vitro diagnostic solution designed by oncology experts for molecular characterization of solid tumors via NGS. For clinical oncology and pathology laboratories.
- VIASURE 16S V1-V4 NGS Solution NGS solution for library preparation aimed at simultaneous identification and profiling of microbial species through analysis of the variable regions V1-V4 of the 16S rRNA gene. Product for research use only.
Companies that use Diagnóstica Longwood
Customer profileSegments2 records
Ideal customer profiles2 records
Diagnóstica Longwood technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Diagnóstica Longwood partnerships and signals
Strategic signalPartnerships
17 partnerships are on record, tiered core and standard.
- IlluminacoreIllumina is a major brand distributed by Diagnóstica Longwood, providing next-generation sequencing solutions, instruments, and reagents for genomic analysis applications including infectious disease surveillance, microbial profiling, and clinical genomics.
- SOPHIA GeneticscoreSOPHIA Genetics provides the SOPHiA DDM platform, an AI-powered clinical genomics analytics platform for variant detection, annotation, and interpretation distributed by Diagnóstica Longwood.
- Yikon GenomicscoreYikon Genomics products include KaryoSeq for preimplantation genetic testing (PGT-M, PGT-SR, PGT-A), MaReCs technology, and reproductive health solutions distributed by Diagnóstica Longwood.
- AgilentcoreAgilent provides SureSelect capture-based enrichment solutions for exome and targeted sequencing, distributed by Diagnóstica Longwood.
- CareDxcoreCareDx specializes in transplantation diagnostics including post-transplant monitoring solutions for chimerism and donor-derived cell-free DNA (dd-cfDNA) testing.
- WerfencoreWerfen provides diagnostic solutions for immunohematology and blood safety, distributed by Diagnóstica Longwood in the Spanish market.
- VarsomecoreVarsome provides CE-IVDR clinical interpretation platforms for NGS data analysis, including VarSome Clinical for germline and somatic variant interpretation.
- Twist BiosciencecoreTwist Bioscience provides synthetic DNA, precision exome solutions, methylation detection systems, and target enrichment solutions for NGS applications.
- Arrow DiagnosticsstandardArrow Diagnostics provides molecular diagnostic kits for microbiology including HIV-1, HCV, HBV solutions and microbiome profiling using NGS technology.
- GenDxstandardGenDx provides NGS solutions for HLA typing, chimerism monitoring, and immunology testing including the NGSengine software platform.
- Inno-train DiagnostikstandardInno-train provides HLA typing solutions including the HLA-SuBiTo NGStype system for high-resolution NGS-based HLA sequencing.
- DevyserstandardDevyser provides targeted NGS solutions for hereditary cancer including BRCA, HBOC, LynchFAP panels, and thalassemia testing.
- HederaDxstandardHederaDx provides targeted NGS panels for solid tumor profiling including FFPE and liquid biopsy applications for pan-cancer analysis.
- CerteststandardCertest provides molecular diagnostic solutions including the VIASURE 16S V1-V4 NGS solution for microbial identification and profiling.
- BrukerstandardBruker provides MALDI-TOF mass spectrometry systems for microbial identification in clinical microbiology laboratories.
- Standard BiotoolsstandardStandard Biotools provides spatial biology solutions including GeoMX and CosMx platforms for spatial transcriptomics and proteomics analysis.
- QiagenstandardQiagen provides sample and assay technologies for molecular diagnostics including automated extraction and PCR solutions.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Diagnóstica Longwood competitors and assessment
Company assessmentDirect peers
- Palex Medical: Spain's largest medical technology and IVD distributor, headquartered in Barcelona with nationwide coverage. Direct competitor in Spanish molecular diagnostics distribution, addressing the same diagnostic and research laboratory customers with comparable multi-brand distribution models.
- Master Diagnóstica: Spanish IVD manufacturer and distributor specializing in molecular biology and infectious disease diagnostics. A direct Spanish competitor operating in overlapping molecular diagnostic product categories.
Broad incumbents
- Werfen: Iberian-headquartered IVD and medical device company with global reach, including the Izasa Scientific distribution arm. Both a partner of Diagnóstica Longwood and a broader incumbent competitor in Spanish IVD distribution, with significantly greater scale and product breadth.
- bioMérieux: Global leader in microbiology diagnostics whose MALDI-TOF and molecular products are distributed by Diagnóstica Longwood in Spain. A broader incumbent competing across the same molecular and infectious disease diagnostic categories.
- Roche Diagnostics: One of the largest IVD manufacturers globally, with deep penetration in Spanish hospital and reference laboratories. Represents both a potential partner and the principal disintermediation risk for distributors operating in molecular diagnostics.
- Qiagen: Sample preparation and molecular diagnostics manufacturer whose products are distributed by Diagnóstica Longwood. A global incumbent in the same molecular biology workflow categories the company serves in Iberia.
- Hologic: Molecular diagnostics manufacturer with strong presence in women's health, virology, and transplant monitoring. Overlaps with Diagnóstica Longwood's infectious disease and transplantation diagnostic product lines in Spain.
- Cepheid (Danaher): Molecular diagnostics leader behind the GeneXpert platform. A direct competitive threat in molecular infectious disease diagnostics across Spanish hospital networks.
- Abbott Diagnostics: Global IVD incumbent with broad molecular diagnostics and immunoassay offerings, widely distributed in Spanish reference laboratories. Competes with Diagnóstica Longwood for the same institutional customers.
Regional players
- Sistemas Genómicos: Spanish genetics and molecular diagnostics laboratory services provider based in Valencia. Regional competitor in hereditary cancer, reproductive genetics, and NGS-based testing in Spain.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Diagnóstica Longwood compliance and trust
Trust signalCompliance2 records
Diagnóstica Longwood financial estimates
Financial estimateRevenue estimate
Valuation estimate
Diagnóstica Longwood leadership team
Management profileNumber of profiles
Diagnóstica Longwood funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Diagnóstica Longwood M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Diagnóstica Longwood
What does Diagnóstica Longwood do?
Diagnóstica Longwood is a specialized distributor of in vitro diagnostic products and solutions for molecular biology. The company curates and distributes products from over 40 international manufacturers spanning NGS, qPCR, fragment analysis, spatial biology, and bioinformatics software. It provides expert scientific consultation, assay setup, protocol development, workflow optimization, and logistics services to clinical diagnostic and research laboratories in Spain and selected international markets.
Is Diagnóstica Longwood a public or private company?
Diagnóstica Longwood is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Diagnóstica Longwood founded?
Diagnóstica Longwood was founded in 1992. It employs 51 to 100 people.
Where is Diagnóstica Longwood based?
Diagnóstica Longwood is headquartered in Zaragoza, Spain, in the Europe region.
How does Diagnóstica Longwood make money?
One revenue line is on record: distribution of In Vitro Diagnostic Products.
Who are Diagnóstica Longwood's main competitors?
Direct peers on record are Palex Medical and Master Diagnóstica. Broad incumbents are Werfen, bioMérieux, Roche Diagnostics, Qiagen, Hologic, Cepheid (Danaher) and Abbott Diagnostics. Sistemas Genómicos is listed as a regional player.
Does Diagnóstica Longwood have an API?
No public API is recorded for Diagnóstica Longwood.
What industry is Diagnóstica Longwood in?
Diagnóstica Longwood's product category is In Vitro Diagnostics Distribution. Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of HLAHAAAC, Microbiology & Infectious Disease Diagnostics (Culture/ID/AST). Its NAICS code is 325413 and its SIC code is 5047.